Pfizer Inc.
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1.3B
Focus Areas
4
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Biohaven | $1.3B |
| ViiV Healthcare | — |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Biohaven | $1.3B |
| ViiV Healthcare | — |